<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Fichtman B</submitter><pubmed_abstract>Nuclear envelopathies comprise a heterogeneous group of diseases caused by mutations in genes encoding nuclear envelope proteins. Mutations affecting lamina-associated polypeptide 1 (LAP1) result in two discrete phenotypes of muscular dystrophy and progressive dystonia with cerebellar atrophy. We report 7 patients presenting at birth with severe progressive neurological impairment, bilateral cataract, growth retardation and early lethality. All the patients are homozygous for a nonsense mutation in the TOR1AIP1 gene resulting in the loss of both protein isoforms LAP1B and LAP1C. Patient-derived fibroblasts exhibit changes in nuclear envelope morphology and large nuclear-spanning channels containing trapped cytoplasmic organelles. Decreased and inefficient cellular motility is also observed</pubmed_abstract><journal>Nature communications</journal><pagination>605</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6363790</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combined loss of LAP1B and LAP1C results in an early onset multisystemic nuclear envelopathy.</pubmed_title><pmcid>PMC6363790</pmcid><pubmed_authors>Spiegel R</pubmed_authors><pubmed_authors>Fichtman B</pubmed_authors><pubmed_authors>Chervinsky E</pubmed_authors><pubmed_authors>Shaag A</pubmed_authors><pubmed_authors>Zagairy F</pubmed_authors><pubmed_authors>Elpeleg O</pubmed_authors><pubmed_authors>Barsheshet Y</pubmed_authors><pubmed_authors>Ben Neriah Z</pubmed_authors><pubmed_authors>Assa M</pubmed_authors><pubmed_authors>Biran N</pubmed_authors><pubmed_authors>Harel A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combined loss of LAP1B and LAP1C results in an early onset multisystemic nuclear envelopathy.</name><description>Nuclear envelopathies comprise a heterogeneous group of diseases caused by mutations in genes encoding nuclear envelope proteins. Mutations affecting lamina-associated polypeptide 1 (LAP1) result in two discrete phenotypes of muscular dystrophy and progressive dystonia with cerebellar atrophy. We report 7 patients presenting at birth with severe progressive neurological impairment, bilateral cataract, growth retardation and early lethality. All the patients are homozygous for a nonsense mutation in the TOR1AIP1 gene resulting in the loss of both protein isoforms LAP1B and LAP1C. Patient-derived fibroblasts exhibit changes in nuclear envelope morphology and large nuclear-spanning channels containing trapped cytoplasmic organelles. Decreased and inefficient cellular motility is also observed</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2026-04-13T17:21:42.54Z</modification><creation>2019-03-26T22:53:24Z</creation></dates><accession>S-EPMC6363790</accession><cross_references><pubmed>30723199</pubmed><doi>10.1038/s41467-019-08493-7</doi></cross_references></HashMap>